Varian

The passionate team members at Varian come from a wide range of technical and clinical backgrounds, but we are all united in our mission to enhance patient outcomes and help build a world without fear of cancer.     "What I’ve found most rewarding about working at Varian is the combination of bench-depth and willingness for collaboration," says Per Halvorsen, the recipient of this year's Marvin M.D. Williams Professional Achievement Award recognizing an outstanding career in medical physics. "Simply put, the access to expert knowledge on nearly any radiation oncology topic is unmatched by any setting I’ve worked in during my 33-year clinical career."     Are you a clinical physicist or dosimetrist interested in joining the team? https://bit.ly/3YeSXrU

Yesterday we had the pleasure of hosting Government of Alberta Minister of Technology and Innovation Nate Glubish and his team at our Palo Alto headquarters. The day was full of passionate discussion about how #government and #business experts can support each other in the never-ending quest to improve patient outcomes. From bolstering the training pipeline of medical experts, to leveraging #ArtificialIntelligence to reduce patient wait times, we're confident the path to progress is through meaningful collaboration. Thank you, Minister Glubish and your team, for your thought partnership and commitment to improving the lives of your constituents.

At Varian, we are dedicated to fostering a culture of diversity, equity, and inclusion, and our recent sponsorship and participation in the #AAPM2024 Women in Physics Luncheon is a testament to that commitment. By empowering women in physics, we aim to foster innovation and contribute to a more equitable and inclusive scientific community. We are proud to have been a part of this inspiring event and look forward to celebrating the achievements of these incredible female scientists. 

We’re excited to share that Varian has received FDA 510(k) clearance for new functionality to its Ethos therapy system! Read the full release here https://bit.ly/3y4nSg7. Introducing a streamlined workflow for daily treatment adaptation across more areas of the body, and providing greater connectivity to patient data, this latest generation reduces complexity, making it easier to implement adaptive, personalized radiotherapy. Ethos 2.0 equips clinical teams with a versatile, comprehensive solution, and optimizes clinical and operational efficiencies with several new and updated features.

It's official - The Varian teams have arrived in beautiful and sunny Los Angeles for #AAPM2024!   We hope you'll stop by to say hi and learn about the latest in cancer care solutions - like Eclipse v18.0, the gateway to future innovation, unlocking a whole new level of precision, efficiency, and consistency in treatment planning.

Congratulations to the National Taiwan University Cancer Center (NTUCC) for completing their HyperArc Clinical Implementation program - designed to enable simplicity, consistency and confidence during stereotactic radiosurgery. “The great thing is that the program helped us review the entire clinical process and optimize every small detail from CT-simulation to plan quality assurance," says Ms. Chia-Jung Wu, Chief Physicist of NTUCC. "We are looking forward to the operational results of this program." We've no doubt that your newly optimized clinical pathway will help you deliver best-in-class to even more patients. #TogetherWeFight 

As the number of people living with cancer rises sharply, there will be an enormous burden on care professionals and our health systems. We believe that digital innovations, including AI, will be key to facing this challenge.     "When you get a cancer diagnosis, every minute counts. But cancer is complex, treatment is complex. No two cancers are alike because no two patients are alike," says Ashley Smith, President of Multi-Disciplinary Oncology at Varian.     "AI is speeding up the cumbersome parts of the process. At every step along the way, it aims to increase efficiency and personalization. Our goal is to help clinicians provide the right treatment at the right time and to ultimately help create a world where people don’t have to fear cancer." 

We've got one day left of the 2024 World Congress of Brachytherapy, and our teams are eager to continue the stimulating conversations around advances in brachytherapy. Stop by our booth to join in the discussion!

In a new study published by Maastro and Erasmus MC Cancer Institute, CBCT images produced by the HyperSight imaging solution are compared to fan-beam CT, ring-gantry CBCT, and C-arm linear accelerator CBCT images.    The study showed that CBCT images produced by HyperSight had increased image quality and noise reduction compared to the other CBCT imagers, while HyperSight and CT imagers had comparable performance for metal artifact reduction (MAR) and extended field-of-view (eFoV) features. These results indicate the potential for adaptive radiotherapy and optimized workflows using the HyperSight imaging solution. https://bit.ly/3LjW7De

Once every four years, the global radiotherapy community gathers for the World Congress of Brachytherapy, and thankfully, 2024 is one of those years.    Brachytherapy is a time-tested method of delivering localized radiation directly to tumors while sparing the surrounding healthy tissues. Despite the long and robust history of this treatment method, our teams are excited to join in conversations about the latest advancements to brachytherapy. See you there!